Suppression of F ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?

Shoaib Faruqi Sean ZhouJoanne ThompsonTerry RobinsonKaren WatkinsHelena CummingsNicola JacksonAnoop PrakashMichael Crooks

Published in: ERJ open research (2019)

F ENO suppression testing is practical and feasible during assessment for biologics in severe asthma. Patients with significant F ENO suppression were less likely to be recommended biologics but saw similar reductions in exacerbation frequency. http://bit.ly/35oSoxP.

Keyphrases

clinical practice
chronic obstructive pulmonary disease
cystic fibrosis
extracorporeal membrane oxygenation
mechanical ventilation